Aptose Biosciences Q4 EPS $(1.44) Beats $(1.59) Estimate
Portfolio Pulse from Benzinga Newsdesk
Aptose Biosciences reported its Q4 earnings with a loss of $(1.44) per share, surpassing the analyst consensus estimate of $(1.59) per share. This represents a 12.73% improvement over the previous year's loss of $(1.65) per share.
March 26, 2024 | 8:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aptose Biosciences reported a smaller than expected quarterly loss, showing improvement over the previous year.
Beating the earnings estimate typically leads to positive investor sentiment, which can drive the stock price up in the short term. The improvement over the previous year's loss further strengthens the case for a positive outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100